Association of fatigue with an acute phase response in sarcoidosis

European Respiratory Journal

Volumn 13, Issue 4, 1999, Pages 718-722

  Drent, M ^a   Wirnsberger, R M ^a   De Vries, J ^b   Van Dieijen Visser, M P ^a   Wouters, E F M ^a   Schols, A M W J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Dept of Pulmonology ^*

Author keywords

Acute phase response; C reactive protein; Fatigue; Metabolic derangement; Sarcoidosis

Indexed keywords

C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE;

ACUTE PHASE RESPONSE; ADULT; ARTICLE; BODY COMPOSITION; CALORIMETRY; CLINICAL ARTICLE; DIET RESTRICTION; ENERGY EXPENDITURE; ENZYME BLOOD LEVEL; EXERCISE; FATIGUE; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REST; SARCOIDOSIS; SOMNOLENCE; SYMPTOM; WEIGHT REDUCTION;

ACUTE-PHASE REACTION; ADULT; BODY COMPOSITION; C-REACTIVE PROTEIN; CALORIMETRY, INDIRECT; CROSS-SECTIONAL STUDIES; ENERGY METABOLISM; EXERCISE TOLERANCE; FATIGUE; FEMALE; HUMANS; MALE; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS, PULMONARY;

EID: 0032937008     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.13d03.x     Document Type: Article

References (30)

1. Müller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical appreciation. Eur Respir J 1998; 11:716-738.
2. Sharma OP, Alam S. Diagnosis, pathogenesis and treatment of sarcoidosis. Curr Opin Pulm Med 1995; 1: 392-400.
3. Hunninghake GW, Gilbert S, Pueringer R, et al. Outcome of the treatment of sarcoidosis. Am J Respir Crit Care Med 1994; 149: 893-898.
4. World Association of Sarcoidosis and other Granulomatous Disorders. Consensus conference: activity of sarcoidosis. Eur Respir J 1994; 7: 624-627.
5. Müller-Quernheim J. The cytokine network in sarcoidosis. Eur Cytokine Netw 1996; 7: 13-26.
6. Drent M, Nierop van MAMF, Gerritsen FA, Wouters EFM, Mulder PGH. Computer program using BALF analysis results as diagnostic tool in interstitial lung diseases. Am J Respir Crit Care Med 1996; 153: 736-741.
7. James DG. Complications of sarcoidosis. Chronic fatigue syndrome. Sarcoidosis 1993; 10: 1-3.
8. Wirnsberger RM, Drent M, Hekelaar N, et al. Relationship between respiratory muscle function and quality of life in sarcoidosis. Eur Respir J 1997; 10: 1450-1455.
9. Anisman H, Baines MG, Berczi I, et al. Neuroimmune mechanisms in health and disease: 2. Disease. Can Med Assoc J 1996; 155: 1075-1082.
10. Highton J. The acute phase response: a clinical perspective. Aust NZ J Med 1984; 14: 173-178.
11. Wirnsberger RM, Vries de J, Wouters EFM, Drent M. Clinical presentation of sarcoidosis in the Netherlands. An epidemiological study. Neth J Med 1998; 53: 53-60.
12. Wirnsberger RM, Vries de J, Breteler MHM, Heck van GL, Wouters EFM, Drent M. Evaluation of quality of life in sarcoidosis patients. Respir Med 1998; 92: 750-756.
13. Quanjer PH, Tammeling GJ, Cotes JE, Pederson OF, Peslin R, Yernault J-C. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests. European Commission for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J 1993; 6: Suppl. 16, 5-40.
14. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis 1969; 99: 696-702.
15. Wilson SH, Cooke NT, Edwards RHT, Spiro SG. Predicted normal values for maximal respiratory pressures in Caucasian adults and children. Thorax 1984; 39: 535-538.
16. DeRemee RA. The roentgenographic staging of sarcoidosis. Chest 1983; 83: 128-133.
17. Schols AMWJ, Buurman WA, Staal-van den Brekel AJ, Dentener MA, Wouters EFM. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with obstructive pulmonary disease. Thorax 1996; 51: 819-824.
18. Ravussin E, Bogardus C. Relationship of genetics, age and physical fitness to daily energy expenditure and fuel utilization. Am J Clin Nutr 1989; 49: 968-975.
19. Karetzky M, McDonough M. Exercise and resting pulmonary function in sarcoidosis. Sarcoidosis 1996; 13: 43-49.
20. Fitting JW, Frascarolo P, Jéquier E, Leuenberger P. Resting energy expenditure in interstitial lung disease. Am Rev Respir Dis 1990; 142: 631-635.
21. Hrycaj P, Wurm K, Mennet P, Müller W. Microheterogenity of acute-phase glycoproteins in patients with pulmonary sarcoidosis. Eur Respir J 1996; 9: 313-318.
22. Asano M, Minagawa T, Ohmichi M, Hiraga Y. Detection of endogenous cytokines in sera or in lymph nodes obtained from patients with sarcoidosis. Clin Exp Immunol 1991; 84: 92-96.
23. 2 release by leukocytic pyrogen (interleukin1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med 1983; 308: 553-558.
24. Fagan EA, Dyck RF, Maton PN, et al. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest 1982; 12: 351-359.
25. Hind CR, Flint KC, Hudspith BN, Felmingham D, Brostoff J, Johnson NM. Serum C-reactive protein concentrations in patients with pulmonary sarcoidosis. Thorax 1987; 42: 332-335.
26. 4 by alveolar macrophages from patients with sarcoidosis. Thorax 1997; 52: 76-83.
27. Drent M, Veizen-Blad van H, Diamant M, Hoogsteden HC, Bosch van den JMM. Relationship between disease presentation of sarcoidosis and T lymphocyte profile: a study in bronchoalveolar lavage fluid. Chest 1993; 104: 795-800.
28. Evans WJ, Campbell WW. Sarcopenia and age-related changes in body composition and functional capacity. J Nutr 1993; 123: 465-468.
29. Landay AL, Jessop C, Lennette ET, Levy JA. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet 1991; 338: 707-712.
30. Voijdani A, Ghoneum M, Choppa PC, Magtoto L, Lapp CW. Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein kinase RNA. J Intern Med 1997; 242: 465-478.